The emerging therapy of tirzepatide peptide represents a major breakthrough in the care of type 2 diabetes. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide717309.mdkblog.com/48247602/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment